Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic Acid in Chronic Ischemic Heart Failure
NCT07725484Phase 3Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Nov 2026
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in ischemic heart failure (IHF), sponsored by Zhongshan Hospital, Fudan University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
ischemic heart failure (IHF)
Beyond the preview
Go deeper on NCT07725484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07725484.